Home / Resources / Polls (page 3)

Polls

CGM for Type 2s

Do you think that having your patients who have type 2 and are not on insulin wear a CGM can improve their numbers? Follow the link to see if you and your colleagues agree.

Read More »

CGM Studies

In your experience, what have most studies about CGM demonstrated?

- HbA1c is lower in CGM users regardless of age or type of insulin delivery.
- Patients using MDI + CGM have greater reductions in HbA1c than those using CSII + CGM.
- Reductions in glycemic variability and time spent in hypoglycemia are not significantly different between SAP and MDI/RT-CGM therapy groups.
- All of the above

Follow the link to see how you and your colleagues compare.

Read More »

What Should CGM Patients Consider?

From your experience: What do you tell your CGM patients they should consider?

A. Determining how long it takes for a change in basal to have an impact on glucose
B. Monitoring 2-hour postprandial excursion to see how well bolus worked
C. Formally testing basals by skipping a meal
D. A and B
E. A, B, and C

Follow the link to share your experience.

Read More »

CGM Candidates

In your opinion, which diabetes patients are the best candidates for CGM?

- Patients on more than five diabetes medications
- Patients unable to achieve their HbA1c goal despite focused efforts
- Patients with frequent or extreme glucose excursions (>200 mg/dL, within day or day-to-day)
- or All of the above?

Follow the link to see how you and your colleagues compare.

Read More »

Real-Time CGM

What percentage of your patients with diabetes would benefit from Real-Time CGM? 0 to 25%, 26% to 50%, 51% to 75%, or 76% to 100%? Follow the link and see how you compare to your colleagues.

Read More »

CGM Reporting

For your patients who use CGM software, do you review the reports generated by the CGM software? Follow the link to see how you compare to your colleagues.

Read More »

Prescribing GLP-1

Would you be more open to prescribing a GLP-1 Inhibitor if there was an oral product rather than an injectable? Follow the link to share your opinion and see what your colleagues think.

Read More »